www.alldocs.info « cancers »
by www.alldocs.info
the most recent document references on :: cancers
Google
 
 Web   cancers.alldocs.info 
 
    Languages: malattie oncologiche  cancers  cancer  cancer  Krebse          Found 1885 documents         Page 57 of 63   Pages:  <<  <  52  53  54  55  56  57  58  59  60  61  62  >  >> 
 
 
 
   cancers cancers
     lung cancer lung cancer
  cancers.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [1681] Norfolk and Waveney Lung Cancer Support Group
      DOC [21,0 KB]  From [www.cancernw.com]  Last viewed: 13.07.2004
  lung  cancer        Norfolk and Waveney Lung Cancer Support Group     Did you know there is a local support group?   The Norfolk and Waveney Lung Cancer Support Group held its first meeting in May 2003.   The meeting is held at the Norfolk and Norwich Hospital and, following the good response to the first two meetings, it is intended to hold further meetings twice a year, in May and November.   What is the meeting about?   First of all ? it is your meeting.  The morning is friendly and relaxed with the opportunity to meet people in similar situations. Health professionals have given talks on topics such as diet and cancer and breathlessness. The Question and Answer session is very popular and gives you and your family the opportunity to tell us about your experiences (good and bad). Past suggestions and comments have been used to improve ...

  [1682] Lung Cancer
      DOC [45,1 KB]  From [employees.oneonta.edu]  Last viewed: 13.07.2004
  lung  cancer  Biology 207 Biology of Cancer     Spring 2004 Lecture 15:  Lung Cancer   Reading:  Page 92 of Scientific American issue, ?What you need to know about cancer ?.   Web sources: www.lungcancer.org ; www.cancerindex.org/geneweb/X1501.htm www.rad.kume.edu/nucmed/clinical/pet_lung.htm   Lecture outline: 1.  Causes of lung cancer 2.  Lung cancer statistics 3.  Diagnosis 4.  Types of lung cancer /staging 5.  Cancer genes associated with lung cancer 6.  Treatment/prospects of survival 7.  Lung as site of secondary tumors   Lecture:   1.  Major causes of lung cancer :   cigarette smoking (85-90% of cases) asbestos workers (3-4%) chemicals (benzopyrene, chromium, nickel, arsenic) radiation exposure ...

  [1683] LUNG CANCER
      PDF [103,2 KB]  From [www.cip-elsevier.com]  Last viewed: 13.07.2004
Gemma Schaepman, Senior Account Manager C.I.P. – Conference Information Publishing, P.O. Box 993, 1000 AZ Amsterdam, The Netherlands Tel: (+31) 20 485 2930 Fax: (+31) 20 485 2940 E-mail: g.schaepman@elsevier.com www.cip-elsevier.com LUNG CANCER Journal of the International Association For the Study of Lung Cancer (IASLC) EDITOR-IN CHIEF: H.H. Hansen Department of Oncology, The Finsen Institute Righospitalet, Copenhagen, Denmark ABSTRACTED/INDEXED IN: Current Contents/Clinical Medicine; Excerpta Medica (EMBASE); Index Medicus (MEDLINE); Oncology Information Service; SciSearch; Current Awareness in Biological Services (CABS) IMPACT FACTOR/RANKING: 2.451 43/114 Oncology 9/32 Respiratory Systems SCOPE : Lung Cancer aims to provide all members of the International Association for the Study of Lung ...

  [1684] Gordon Stone Susan Vaughan Geoffrey Hulks Ruth Innes LUNG CANCER ...
      PDF [414,5 KB]  From [www.show.scot.nhs.uk]  Last viewed: 13.07.2004
Recent changes in lung cancer incidence for south Asians Lucy K Smith, Michael D Peake, Johannes L Botha In England, the incidence of lung cancer among south Asians (Indian, Pakistani, and Bangladeshi) is much lower than in the rest of the population. 1 In the UK, south Asian population, however, it is the commonest cancer for men and the second commonest for women. 2 We explored trends in lung cancer incidence from 1990 to 1999 in Leicester (22% of residents classified as south Asian in 1991 census). Participants, methods, and results We identified cases of lung cancer diagnosed in Leicester residents between 1 January 1990 and 31 December 1999 from the Trent Cancer Registry. Ethnicity data were not available for all patients, so we used software assessing forename and surname to classify patients as ...

  [1685] Chemotherapy in Non-Small Cell Lung Cancer: An Update
      PDF [423,7 KB]  From [www.ctu.mrc.ac.uk]  Last viewed: 13.07.2004
Chemotherapy in Non-Small Cell Lung Cancer : An Update A meta-analysis of randomised trials using individual patient data Protocol C Comparison 3 Surgery + Radiotherapy vs Surgery +Radiotherapy + Adjuvant Chemotherapy Conducted by the Non-Small Cell Lung Cancer Collaborative Group (NSCLCCG) May 2004 Page 2 Protocol C surgery + radiotherapy vs surgery + radiotherapy + chemotherapy NSCLC Collaborative Group Secretariat Comparisons 1, 2 & 7 please contact Meta-analysis Group MRC Clinical Trials Unit 222 Euston Road London NW1 2DA UK Fax: +44 (0)20 7670 4816 Sarah Burdett email: sb@ctu.mrc.ac.uk tel: +44 (0)20 7670 4722 Lesley Stewart email: ls@ctu.mrc.ac.uk tel: +44 (0)20 7670 4724 Richard ...

  [1686] 9 OUT OF 10 LUNG CANCER CASES ARE CAUSED BY SMOKING. NEUF CAS DE ...
      PDF [138,2 KB]  From [www.porcupinehu.on.ca]  Last viewed: 13.07.2004
9 OUT OF 10 LUNG CANCER CASES ARE CAUSED BY SMOKING. NEUF CAS DE CANCER DU POUMON SUR DIX SONT ATTRIBUABLES À L'USAGE DU TABAC. With funding from the Government of Ontario Grâce à un financement du gouvernement de l'Ontario Page 2 www.porcupinehu.on.ca L’usage du tabac nuit au personnel de l’industrie de l’accueil Le saviez-vous? - Les employés des bars et des tavernes ont des taux plus élevés de cancer du poumon que tout autre employé. - La fumée non filtrée s’échappant de l’extrémité d’une cigarette contient une plus forte concentration de substances dangereuses que la fumée inhalée par le fumeur. Bien entendu, les fumeurs sont exposés aux deux types de fumée. - S’il s’agit d’un établissement achalandé et que les employés travaillent fort, ils inhaleront encore plus de fumée secondaire ...

  [1687] Women and Lung Cancer: News You Can Use
      PDF [55,2 KB]  From [www2.mdanderson.org]  Last viewed: 13.07.2004
OncoLog • February 2003 7 P H Y S I C I A N S : T H I S P A T I E N T I N F O R M A T I O N S H E E T I S Y O U R S T O C O P Y A N D P A S S O N T O P A T I E N T S . For more information, contact your physician or contact the M. D. Anderson Information Line: ? (800) 392-1611 within the United States, or ? (713) 792-6161 in Houston and outside the United States. February 2003 ©2003 The University of Texas M. D. Anderson Cancer Center Women and Lung Cancer : News You Can Use Since 1950, the number of women who die of lung cancer each year has increased 600%, according to a 2001 Surgeon General’s report on “Women and Smoking.” More than 22 million women and 1.5 million adolescent girls in the United States smoke cigarettes, and the number of smokers is increasing ...

  [1688] P3090/Lung Cancer Report20 page
      PDF [142,7 KB]  From [www.cancercare.on.ca]  Last viewed: 13.07.2004
Clinical Focus on Lung Cancer A snapshot of lung cancer for Ontario health care providers and managers Driving quality, accountability and innovation throughout Ontario’s cancer system Page 2 C LINICAL F OCUS ON L UNG C ANCER Prepared by: Dr. W.K. (Bill) Evans Chief Medical Officer and Provincial Vice-President Cancer Care Ontario and Chair, Lung Disease Site Group With the Assistance of: Dr. Terrence Sullivan Deborah Fitzsimmons Dr. Eric Holowaty Alex Drossos Dr. Anthony Whitton Mark Gregus Dr. Brent Zanke Diane Nishri Dr. Loraine D. Marrett Saira Bahl Ian Brunskill Sherman Quan Beth Theis Bev Hess May 2004 T ABLE OF ...

  [1689] General Practitioner in Oncology Self-directed Learning Program ...
      PDF [110,6 KB]  From [www.cancercare.on.ca]  Last viewed: 13.07.2004
General Practitioner in Oncology Self-directed Learning Program LUNG CANCER MODULE Page 2 Lung Cancer Case Scenario 1 A 65-year-old man presents with a 6- week history of cough, progressive SOB and a 20-pound weight loss. He has a 50-pack year smoking history and his family doctor orders a chest x-ray and blood work. The chest x-ray shows a left lower lobe mass. A CT scan of the thorax shows mediastinal lymph nodes confined to the left hemithorax. 1. What tests are required to properly stage this patient? 2. Assuming his disease is confined to the chest, what stage is this man’s small cell lung cancer ? 3. How does staging for small cell lung cancer differ from non-small cell lung cancer ? 4. With respect to staging in small cell lung cancer , how would stage be affected if the patient ...

  [1690] Non small-cell lung cancer, mesothelioma, and thymoma
      PDF [187,2 KB]  From [www.thymic.org]  Last viewed: 13.07.2004
NON–SMALL-CELL LUNG CANCER , MESOTHELIOMA, AND THYMOMA 123 CHAPTER 7 Non–small-cell lung cancer , mesothelioma, and thymoma Robert J. McKenna, Jr., MD , Benjamin Movsas, MD , Dong M. Shin, MD , and Fadlo R. Khuri, MD In the United States, lung cancer has been the leading cause of cancer death in men for years, and since 1988, it has become the number-one cause of cancer death in women. It is estimated that 171,900 new cases of lung cancer will be diagnosed in 2003, and 157,200 deaths due to this disease will occur. This exceeds the combined number of deaths from the second, third, and fourth leading causes of cancer (breast, prostate, and colon cancer , respectively). Lung cancer appears to develop from a stem cell that can differentiate along multiple lines. Although ...

  [1691] LUNG CANCER MORTALITY IN A DISTRICT OF LA SPEZIA (ITALY) EXPOSED ...
      PDF [186,9 KB]  From [www.pensiero.it]  Last viewed: 13.07.2004
Tumori, 90: 181-185, 2004 Introduction In Italy, lung cancer is the leading cause of cancer mortality in men and the third (after breast and intesti- nal) in women, causing over 31,000 deaths in 1997 1 . The mortality trend showed a nearly linear rise in males until 1987-1988, followed by a drop of about 16% in the 9 years thereafter, with age standardized rates rang- ing from 60.3 to 50.6 per 100,000 inhabitants (stan- dard: world population). In contrast, the corresponding figures for females (7.9 per 100,000 inhabitants in 1997) have not displayed any clear decline in recent years 1 . Although cigarette smoking is known to be by far the main factor responsible for the observed differences in lung cancer occurrence among different populations 2 , several epidemiologic studies have implicated outdoor environmental ...

  [1692] Fact sheet-lung cancer (Page 2)
      PDF [737,7 KB]  From [www.brighamandwomens.org]  Last viewed: 13.07.2004
M ARY H ORRIGAN C ONNORS C ENTER FOR W OMEN ’ S H EALTH AND G ENDER B IOLOGY P OLICY I SSUES IN W OMEN ’ S H EALTH : L UNG C ANCER AND S MOKING Lung cancer mortality rates among women have increased by 600% since 1950. 1 In 2001, lung cancer was the leading cause of cancer death for women in Massachusetts, surpassing breast cancer , and accounting for 24% of all deaths. The lung cancer mortality rate among women in Massachusetts increased from 43.3 per 100,000 in 1989 to 51.2 in 1998. Although the mortality rate from lung ...

  [1693] Lung Cancer
      PDF [90,0 KB]  From [www.preventcancer.org]  Last viewed: 13.07.2004
Lung Cancer Lung cancer is the leading cause of cancer deaths for both men and women. Death rates are declining in men but continue to increase in women. Tobacco use is the most important risk factor for lung cancer . PREVENTION • Don’t use tobacco in any form • If you use tobacco, quit • Create smoke-free environments in your community RISKS • People who use tobacco in any form • People who have had exposure to substances such as arsenic, radon and asbestos • People whose occupation exposes them to radiation • People exposed to second-hand smoke • All people exposed to air pollution and environmental smoke are at some risk SYMPTOMS In the early stages, there may be no symptoms • Persistent cough • Sputum (spit) streaked with blood • Chest pain • Recurring pneumonia or bronchitis ...

  [1694] Lung Cancer
      PDF [40,5 KB]  From [www.stlukesonline.org]  Last viewed: 13.07.2004
Lung Cancer When it comes to cancer , knowledge is good medicine. More men and women die of lung cancer than any other type of cancer in the United States. In recent years, more women have died from lung cancer than even breast cancer , because more women continue to smoke. Cigarette smoking is by far the most important preventable cause of lung cancer . Tobacco is linked to 87 percent of all lung cancer cases. Other factors include exposure to: • Industrial substances (such as chemicals and asbestos) • Radiation exposure from occupational, medical and environmental sources • Air pollution • Radon exposure People who smoke cigarettes and have exposure to other risk factors have an even greater chance of developing cancer of the lung . Second-hand tobacco smoke increases lung cancer risk for nonsmokers. The good news is studies show that ...

  [1695] Fact sheet-lung cancer (Page 2)
      PDF [737,7 KB]  From [www.brighamandwomens.org]  Last viewed: 13.07.2004
M ARY H ORRIGAN C ONNORS C ENTER FOR W OMEN ’ S H EALTH AND G ENDER B IOLOGY P OLICY I SSUES IN W OMEN ’ S H EALTH : L UNG C ANCER AND S MOKING Lung cancer mortality rates among women have increased by 600% since 1950. 1 In 2001, lung cancer was the leading cause of cancer death for women in Massachusetts, surpassing breast cancer , and accounting for 24% of all deaths. The lung cancer mortality rate among women in Massachusetts increased from 43.3 per 100,000 in 1989 to 51.2 in 1998. Although the mortality rate from lung ...

  [1696] Lung Cancer - Frequently Asked Questions
      PDF [94,7 KB]  From [www.4woman.gov]  Last viewed: 13.07.2004
Frequently Asked Questions about Lung Cancer What is lung cancer ? Cancer is a disease in which certain body cells don’t function right, divide very fast, and produce too much tissue that forms a tumor. The lungs, a pair of sponge-like, cone-shaped organs, are part of the body’s respiratory system. When we breathe in, the lungs take in oxygen, which our cells need to live and carry out their normal functions. When we breathe out, the lungs get rid of carbon dioxide, which is a waste product of the body's cells. Cancers that begin in the lungs are divided into two major types, non-small cell lung cancer and small cell lung cancer , depending on how the cells look under a microscope. Each type of lung cancer grows and spreads in different ways and is treated differently. Why should I be concerned about lung cancer ? Did you know that lung cancer ...

  [1697] Lung Cancer Miscellaneous Clinical Trials
      PDF [228,4 KB]  From [www.mc.vanderbilt.edu]  Last viewed: 13.07.2004
VICC THO 0214 Phase II: OSI- 774 (Tarceva) in Pts with Advanced BAC Bronchioloalveolar 1st or 2nd Line 1st or 2nd Line Mesothelioma Lung Cancer Miscellaneous Clinical Trials VICC SAR 0269 Phase II: SDX-102 for NSCLC pts with MTAP- deficient cancer K E Y Pending Suspended Open Revised Team Leader Signature and Date Revised 5/17/04

  [1698] Strongest Study Yet Links Small Pollution Particles to Lung Cancer
      PDF [61,7 KB]  From [www.seedcoalition.org]  Last viewed: 13.07.2004
FOR IMMEDIATE RELEASE CONTACT Karen Hadden Tuesday, March 5, 2002 512-797-8481 Strongest Study Yet Links Small Pollution Particles to Lung Cancer Shows the Need to Clean up Power Plant Sulfur and the Skies Over Big Bend National Park A study released today by the Journal of the American Medical Association shows that exposure to air pollution with high levels of tiny particles of dust and soot significantly increases the risk of dying from lung cancer and heart disease. “The new study provides the strongest data yet that exposure to fine particles (PM 2.5 ) is linked with lung cancer and cardiopulmonary mortality. Particle air pollution is common in many U.S. cities, and is a large part of the haze that obscures vistas in national parks, such as Big Bend in Texas,” noted Karen Hadden, Clean Air Coordinator for the SEED (Sustainable ...

  [1699] EGFR Mutations in Lung Cancer: Correlation with Clinical Response ...
      PDF [358,4 KB]  From [www-biology.ucsd.edu]  Last viewed: 13.07.2004
/ www.sciencexpress.org / 29 April 2004 / Page 1/ 10.1126/science.1099314 Receptor tyrosine kinase genes were sequenced in non- small cell lung cancer (NSCLC) and matched normal tissue. Somatic mutations of the epidermal growth factor receptor gene EGFR were found in 15 of 58 unselected tumors from Japan and 1 of 61 from the United States. Treatment with the EGFR kinase inhibitor gefitinib (Iressa) causes tumor regression in some patients with NSCLC, more frequently in Japan. EGFR mutations were found in additional lung cancer samples from U.S. patients who responded to gefitinib therapy and in a lung adenocarcinoma cell line that was hypersensitive to growth inhibition by gefitinib, but not in gefitinib- insensitive tumors or cell lines. These results suggest that EGFR mutations may predict sensitivity to gefitinib. Protein kinase activation by somatic ...

  [1700] USING SPLINES TO ANALYSE THE RADON EXPOSURE-TIME- LUNG CANCER RISK ...
      PDF [44,1 KB]  From [www.sante.univ-nantes.fr]  Last viewed: 13.07.2004
Rogel, A 1 USING SPLINES TO ANALYSE THE RADON EXPOSURE-TIME- LUNG CANCER RISK IN URANIUM MINER’S COHORT Author's name(s) : Rogel A.*, Fouillet A., Laurier D., Tirmarche M. Affiliation(s) : Laboratoire d’Epidémiologie, Institut de Radioprotection et Sûreté Nucléaire BP n°17, 92262 Fontenay-aux-Roses Cedex. France. Email: agnes.rogel@irsn.fr Phone : 33-1-58-35-74-27; Fax: 33-1-46-57-03-86 Topic area : Statistics in Cancer Research Keywords : Radon, Exposure-time-risk, B-splines Abstract Research objectives Numerous studies have shown a significant increase in death from lung cancer related to radon exposure among uranium miner’s 1 . Uncertainty still remains concerning the exposure- risk relationship at low levels, in part due to imprecise knowledge of the effect of time- dependent modifying factors, such as time since exposure ...

  [1701] Tarceva drug extends life in lung cancer patients Louvre officials ...
      PDF [395,2 KB]  From [www.myanmargeneva.org]  Last viewed: 13.07.2004
THE NEW LIGHT OF MYANMAR Thursday, 29 April, 2004 13 Tarceva drug extends life in lung cancer patients Z URICH /N EW Y ORK , 28 April — An experimental lung cancer drug extended patients’ life-expectancy by a third in a late-stage clinical trial reported on Monday, a potential breakthrough that pumped adrenalin into biotechnology shares. The drug, Tarceva, which is being developed by OSI Pharmaceuticals Inc., Genentech Inc. and Roche Holding AG, was tested in patients who had failed to respond to chemotherapy. “It’s a giant leap forward for lung cancer patients,” said Dr. Roy Herbst, chief of the lung cancer division at the University of Texas MD Anderson Cancer Center in Houston. About 170,000 lung can- cer sufferers die in the United States ...

  [1702] Spiral CT for Lung Cancer Screening
      PDF [179,5 KB]  From [www.cigna.com]  Last viewed: 13.07.2004
C IGNA H EALTH C ARE C OVERAGE P OSITION Subject: Spiral Computed Tomography (CT) For Lung Cancer Screening Coverage Position Number: 0007 Effective Date: 2/15/2004 Table of Contents: Related Coverage Positions: Coverage Position.. 1 General Background . 1 Coding/Billing Information .. 2 References. 2 INSTRUCTIONS FOR USE Coverage Positions are intended to supplement certain standard CIGNA HealthCare benefit plans. Please note, the terms of a participant’s particular benefit plan document [Group Service Agreement (GSA), Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans ...

  [1703] Lung Cancer Screening with Sputum Cytologic Examination, Chest ...
      PDF [305,7 KB]  From [www.ahrq.gov]  Last viewed: 13.07.2004
Screening for lung cancer is not currently recommended by any major medical professional organization. The U.S. Preventive Services Task Force (USPSTF) gave lung cancer screening a “D” recommendation in both 1985 and 1996, meaning that there were fair-quality data to recommend against screening for lung cancer 1 based largely on 3 negative trials conducted in the United States in the 1970s. Since the last Task Force review, several new studies of lung cancer screening have been reported, and greater attention has been directed toward the limitations of existing literature. This review was conducted to aid the current USPSTF in updating its lung cancer screening recommendation. Lung cancer is the leading cause of cancer -related death among men and women in the United States; in 2003, approximately 171,900 new cases and 157,200 ...

  [1704] The Impact of PET on the Management of Lung Cancer: The Referring ...
      PDF [84,4 KB]  From [www.stanfordhospital.com]  Last viewed: 13.07.2004
The Impact of PET on the Management of Lung Cancer : The Referring Physician’s Perspective Marc A. Seltzer, MD 1 ; Cecelia S. Yap, BS 1 ; Daniel H. Silverman, MD, PhD 1 ; Joubin Meta, BS 1 ; Christiaan Schiepers, MD, PhD 1 ; Michael E. Phelps, PhD 1 ; Sanjiv S. Gambhir, MD, PhD 1 ; Jyotsna Rao, MD 2 ; Peter E. Valk, MD 2 ; and Johannes Czernin, MD 1 1 Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Clinic/Nuclear Medicine, UCLA School of Medicine, Los Angeles, California; and 2 Northern California PET Imaging Center, Sacramento, California 18 F-FDG PET is a molecular whole-body imaging modality that is increasingly being used for diagnosing, staging, and restaging cancer ...

  [1705] 072700 Preoperative Staging of Non Small-Cell Lung Cancer
      PDF [254,5 KB]  From [www.stanfordhospital.com]  Last viewed: 13.07.2004
254 · Ju l y 2 7 , 2 0 0 0 The Ne w E n g l a nd Jo u r n a l o f Me d ic i ne PREOPERATIVE STAGING OF NON–SMALL-CELL LUNG CANCER WITH POSITRON-EMISSION TOMOGRAPHY R EMGE M. P IETERMAN , M.D., J OHN W.G. VAN P UTTEN , M.D., J ACOBUS J. M EUZELAAR , M.D., E DUARD L. M OOYAART , M.D., W ILLEM V AALBURG , P H .D., G ERARD H. K OËTER , M.D., V ACLAV F IDLER , P H .D., J AN P RUIM , M.D., AND H ARRY J.M. G ROEN , M.D. A BSTRACT Background Determining the stage of non–small- ...

  [1706] RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Lung Cancer
      PDF [65,6 KB]  From [www.mass.gov]  Last viewed: 13.07.2004
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Source: Community Assessment Unit, Bureau of Environmental Health Assessment, Massachusetts Department of Public Health December, 2002 Lung Cancer Lung cancer generally arises in the epithelial tissue of the lung . Several different histologic or cell types of lung cancer have been observed. The various types of lung cancer occur in different regions of the lung and each type is associated with slightly different risk factors (Blot and Fraumeni 1996). The most common type of lung cancer in the United States today is adenocarcinoma which accounts for about 40% of all lung cancers (ACS, 2000). The greatest established risk factor for all types of lung cancer is cigarette smoking, followed by occupational and environmental exposures. The incidence of lung cancer increases sharply ...

  [1707] RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Lung Cancer
      PDF [86,6 KB]  From [www.mass.gov]  Last viewed: 13.07.2004
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Lung Cancer Lung cancer generally arises in the epithelial tissue of the lung . Several different histologic or cell types of lung cancer have been observed. The various types of lung cancer occur in different regions of the lung and each type is associated with slightly different risk factors (Blot and Fraumeni 1996). The most common type of lung cancer in the United States today is adenocarcinoma which accounts for about 40% of all lung cancers (ACS, 2000). The greatest established risk factor for all types of lung cancer is cigarette smoking, followed by occupational and environmental exposures. The incidence of lung cancer increases sharply with age peaking at about age 60 or 70. Lung cancer is very rare in people under the age of 40. The incidence is greater among men than ...

  [1708] RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Lung Cancer
      PDF [68,1 KB]  From [www.mass.gov]  Last viewed: 13.07.2004
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Source: Community Assessment Unit, Bureau of Environmental Health Assessment, Massachusetts Department of Public Health July, 2001 Lung Cancer Lung cancer generally arises in the epithelial tissue of the lung . Several different histologic or cell types of lung cancer have been observed. The various types of lung cancer occur in different regions of the lung and each type is associated with slightly different risk factors (Blot and Fraumeni 1996). The most common type of lung cancer in the United States today is adenocarcinoma which accounts for about 40% of all lung cancers (ACS, 2000). The greatest established risk factor for all types of lung cancer is cigarette smoking, followed by occupational and environmental exposures. The incidence of lung cancer increases sharply with age peaking ...

  [1709] Lung Cancer Screening
      PDF [207,7 KB]  From [www.ahrq.gov]  Last viewed: 13.07.2004
Summary of Recommendation The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend for or against screening asymptomatic persons for lung cancer with either low dose computerized tomography (LDCT), chest x-ray (CXR), sputum cytology, or a combination of these tests. I recommendation. The USPSTF found fair evidence that screening with LDCT, CXR, or sputum cytology can detect lung cancer at an earlier stage than lung cancer would be detected in an unscreened population; however, the USPSTF found poor evidence that any screening strategy for lung cancer decreases mortality. Because of the invasive nature of diagnostic testing and the possibility of a high number of false-positive tests in certain populations, there is potential for significant harms from screening. Therefore, the ...

  [1710] Lung Cancer in Kalamazoo County
      PDF [137,5 KB]  From [www.kalcounty.com]  Last viewed: 13.07.2004
Kalamazoo County Human Services Department Volume I ? Number 3 www.kalcounty.com July 2002 Lung Cancer in Kalamazoo County ? In 1999, 128 cases of lung cancer were diagnosed in Kalamazoo County residents (Table 1). The average number of cases remained stable from 1990-94 (134.6 cases) to 1995-99 (135 cases). ? During much of the 1990s lung cancer incidence rates in the county were lower than the state (Figure 1). The 1995-99 average county rate was 6.7 compared to the MI rate of 7.5 per 10,000. ? Ninety-seven deaths in the county were attributed to lung cancer during 2000 accounting for 25% of all county cancer related deaths (Table 1). ? In 2000 the lung cancer mortality rate in the county was 4.7 per 10,000 compared to the Michigan rate ...